Antithrombotic management in catheter ablation for ventricular arrhythmias - Mini review

Abstract

Radiofrequency catheter ablation (RFCA) is a common treatment option for ventricular arrhythmias (VA). Risks of RFA for VA include emboli and bleeding complications. In contrast to atrial fibrillation ablation procedures, for which anticoagulation therapy is relatively well standardized, peri-procedural antithrombotic therapy practices for RFCA of VA vary among laboratories and remains an area of investigation. This summary focuses on the current evidence-based antithrombotic therapies of RFCA for VA, with a particular emphasis on two recent major studies.

Keywords: Ablation; Antithrombotic therapy; Complication; Stroke; Ventricular arrhythmia.